A Phase 2b Randomized Study to Assess the Efficacy and Safety of the Combination of Ublituximab + TGR-1202 and TGR-1202 alone in Patients with Previously Treated Diffuse Large B-Cell Lymphoma - Regional Cancer Care Associates LLC

Clinical Trials

A Phase 2b Randomized Study to Assess the Efficacy and Safety of the Combination of Ublituximab + TGR-1202 and TGR-1202 alone in Patients with Previously Treated Diffuse Large B-Cell Lymphoma

Type of Cancer
Lymphoma
Locations
Bethesda
Sponsor
TG Therapeutics, Inc.
Protocol Number
UTX-TGR-205
Cancer Diagnosis
To Learn More Call
201-510-0910